In another study, the anti-TNF-α antibody adalimumab was shown to bind to membrane TNF-α expressed by monocytes and to promote Treg expansion by paradoxically enhancing TNFR2-mediated signaling in RA patients (55). This evidence concerns the gene TNF and rheumatoid arthritis.